Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Kansas City, Kansas 66160


Epistaxis is a common problem among people of all ages and backgrounds. However, occasionally epistaxis can be severe enough to require emergency room admission. Among the treatment options for epistaxis, nasal packing is the most common approach. This approach requires a return visit to the clinic for removal of the packing. Additionally, there is a great deal of pain during the insertion and removal of this packing. This study aims to justify the further investigation of thrombin as a potential treatment approach for these patients. Thrombin could provide a treatment approach that reduces pain and eliminates the need for a return visit to the clinic.


Inclusion Criteria: - English speaking adults that have failed first line therapy for anterior epistaxis in the ER or the hospital Exclusion Criteria: - Non-english speaking patients - Patients with bleeding disorders - Known pregnant women or women that think they may be pregnant - Patients with a know presence of antibodies to bovine thrombin preparations - Patients that currently have or are known to have a history of systemic skin condition or rash such as eczema or psoriasis - Patients found to have posterior epistaxis - Patients requiring a surrogate for medical decisions



Primary Contact:

Principal Investigator
Keith Sale, MD
University of Kansas

Backup Contact:


Location Contact:

Kansas City, Kansas 66160
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.